-
Another “Double-Dose” Pill Problem Demonstrates How And Why The Digitek Recall Is So Unusual
June 2008 Drug Recall By ETHEX Is Similar To Digitek Recall, But Here The Drug Company Is Able To Provide Specific Information About Dates And Lot Numbers, Unlike Actavis (Posted by Tom Lamb at…
-
Do Enbrel, Humira, Or Remicade Cause Cancer In Children And Young Adults?
FDA Will Conduct A Safety Review Of These TNF Blockers To Investigate This Possible Link (Posted by Tom Lamb at DrugInjuryWatch.com) On June 4, 2008 the FDA issued an "Early Communication About an Ongoing…
-
Adverse Drug Reactions Lead To Significant Number Of ER Visits Each Year
New Canadian Study Highlights Link Between Some Medications And Serious Health Problems (Posted by Tom Lamb at DrugInjuryWatch.com) A June 3, 2008 article, "More than 1 in 9 ER visits medication-related", in The Globe and…
-
June 2008 FDA Meeting Will Address Problem Of Look-alike And Sound-alike Drug Names
Confusion Between Similar Drugs Is A Cause Of Medication Errors That Agency Will Focus On In New Pilot Program (Posted by Tom Lamb at DrugInjuryWatch.com) To start, we get this background information from "Medication…
-
Digitek Update May 2008: When Old News Is Better Than No News At All
A Month After FDA Class 1 Digitek Recall, We Have Been Told Little About Actavis Manufacturing Problem (Posted by Tom Lamb at DrugInjuryWatch.com) More than thirty days have passed since Actavis Totowa first announced…
-
Actavis Tells Us More, But Not Much More, About April 2008 Digitek Recall
Actavis, Mylan, Or The FDA Should Tell Public Their Current Estimate Of How Many Defective Digitek Pills Were Distributed To Pharmacies, And During What Time Period (Posted by Tom Lamb at DrugInjuryWatch.com) On May…
